Smith & Nephew SNATS, Inc. $SNN Stock: Quadrant Capital Group LLC Decreases Stake

Quadrant Capital Group LLC decreased its stake in shares of Smith & Nephew SNATS, Inc. (NYSE:SNN) by 67.3% during the third quarter, HoldingsChannel.com reports. The fund owned 13,457 shares of the medical equipment provider’s stock after selling 27,717 shares during the period. Quadrant Capital Group LLC’s holdings in Smith & Nephew SNATS were worth $375,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in the stock. Mitsubishi UFJ Asset Management Co. Ltd. acquired a new position in Smith & Nephew SNATS during the second quarter valued at approximately $13,812,000. Grandfield & Dodd LLC bought a new position in shares of Smith & Nephew SNATS in the second quarter valued at approximately $13,192,000. Public Employees Retirement System of Ohio bought a new position in shares of Smith & Nephew SNATS in the second quarter valued at approximately $2,170,000. Teachers Retirement System of The State of Kentucky lifted its stake in shares of Smith & Nephew SNATS by 51.0% in the first quarter. Teachers Retirement System of The State of Kentucky now owns 905,100 shares of the medical equipment provider’s stock worth $28,764,000 after buying an additional 305,600 shares during the last quarter. Finally, BlackRock Inc. acquired a new stake in shares of Smith & Nephew SNATS in the second quarter worth $505,323,000. Institutional investors and hedge funds own 25.64% of the company’s stock.

Smith & Nephew SNATS Price Performance

SNN opened at $30.48 on Tuesday. Smith & Nephew SNATS, Inc. has a 1-year low of $26.12 and a 1-year high of $37.09. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.14 and a quick ratio of 1.11. The business has a 50 day moving average of $28.26 and a 200-day moving average of $31.17.

Smith & Nephew SNATS Announces Dividend

The business also recently announced a dividend, which will be paid on Friday, November 6th. Investors of record on Friday, October 2nd will be given a dividend of $0.3120 per share. The ex-dividend date of this dividend is Friday, October 2nd. This represents a yield of 236.0%.

Wall Street Analyst Weigh In

Several research firms recently issued reports on SNN. Weiss Ratings downgraded shares of Smith & Nephew SNATS from a “hold (c+)” rating to a “hold (c)” rating in a report on Thursday, September 24th. Bank of America downgraded shares of Smith & Nephew SNATS from a “buy” rating to a “neutral” rating in a report on Tuesday, September 8th. Barclays lowered shares of Smith & Nephew SNATS from an “equal weight” rating to an “underweight” rating in a research report on Wednesday, August 5th. BTIG Research started coverage on shares of Smith & Nephew SNATS in a research report on Monday, August 31st. They set a “neutral” rating for the company. Finally, JPMorgan Chase & Co. restated a “neutral” rating on shares of Smith & Nephew SNATS in a report on Thursday, August 6th. One research analyst has rated the stock with a Buy rating, nine have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Hold” and an average target price of $31.91.

Smith & Nephew SNATS Company Profile

Smith & Nephew plc is a global medical technology company that develops and manufactures products used by healthcare professionals to treat injuries, manage wounds and restore patients’ mobility. Founded in 1856 by Thomas James Smith in Hull, England, the company has grown from a pharmacy business into an international healthcare manufacturer.

The company operates across three principal areas: orthopaedics, sports medicine and ear, nose and throat (ENT), and advanced wound management.